Claudia Duranti
Florence, 50134, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
KV11.1 (hERG1)-centered macromolecular membrane complexes regulate proliferation in B cell lymphomas and constitute novel pharmacological targets.
Journal: Pharmacological research
Published: July 17, 2025
Clinical relevance of macromolecular complexes involving integrins, potassium and sodium ion channels and the sodium/proton antiporter in human breast cancer.
Journal: Cancer cell international
Published: August 10, 2024
Antineoplastic Activity of a Novel Trispecific Single-Chain Antibody Targeting the hERG1/β1 Integrin Complex and TRAIL Receptors.
Journal: Molecular cancer therapeutics
Published: July 31, 2024
Targeting the hERG1 and β1 integrin complex for cancer treatment.
Journal: Expert opinion on therapeutic targets
Published: February 19, 2024
Cardiac safety assessment of a novel recombinant bispecific antibody targeting the ether-à-go-go related gene 1 (hERG1)-β1 integrin macromolecular complex.
Journal: Frontiers in pharmacology
Published: June 09, 2023
Integrins regulate hERG1 dynamics by girdin-dependent Gαi3: signaling and modeling in cancer cells.
Journal: Life science alliance
Published: May 06, 2023
Combination Therapy with a Bispecific Antibody Targeting the hERG1/β1 Integrin Complex and Gemcitabine in Pancreatic Ductal Adenocarcinoma.
Journal: Cancers
Published: February 04, 2023
Expression of the ether-a-gò-gò-related gene 1 channel during B and T lymphocyte development: role in BCR and TCR signaling.
Journal: Frontiers in immunology
Published: November 29, 2022
Prognostic role of hERG1 Potassium Channels in Neuroendocrine Tumours of the Ileum and Pancreas.
Journal: International journal of molecular sciences
Published: August 01, 2022
Last Updated: 09/26/2026